Dr. Arvind Balavenkataraman, MD

Dr. Balavenkataraman practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Balavenkataraman's NPI, 1275813354, was assigned on August 22, 2011. Dr. Balavenkataraman graduated from Other in 2009. Dr. Balavenkataraman holds Florida license ME149843.

Dr. Balavenkataraman's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Balavenkataraman's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. Dr. Balavenkataraman is also affiliated with UF Health Jacksonville. The medical group on file is UF Jacksonville Physicians, Inc. Dmand AI also links Dr. Balavenkataraman to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balavenkataraman practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Balavenkataraman's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Balavenkataraman is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Balavenkataraman's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), pulmonary heart disease and upper respiratory infection (URI) among the conditions Dr. Balavenkataraman treats.

CMS data shows 83 Medicare services from Dr. Balavenkataraman across 3 procedure codes in 2024, for 104 Medicare patients. Medicare paid $12,101 for them.

CMS counts 104 Medicare patients who saw Dr. Balavenkataraman in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Balavenkataraman's median patient age at 69, with 60% women.

In 2024, Dr. Balavenkataraman wrote 248 Medicare Part D claims for 72 patients. 55% of them were for generic drugs. CMS names the drug for 157 of them, across 10 drugs with 11 or more claims each, at $22,594 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Balavenkataraman for performance year 2024, reported as part of a group. Dr. Balavenkataraman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 13 papers to Dr. Balavenkataraman, published from 2012 to 2025. 2024 was the busiest year, with 5. The most frequent topics are COVID-19 and Plasma Volume. Dr. Balavenkataraman has published most often in Lung India. Dr. Balavenkataraman's most frequent co-authors are Prasanth Balasubramanian, MD, Scott A. Helgeson, MD and Neal Mahesh Patel, MD.

CMS Open Payments shows 4 general payments to Dr. Balavenkataraman from 4 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $104.

Dr. Balavenkataraman graduated from Other in 2009.

Dr. Balavenkataraman is in network with 7 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.